ArticleJournal of endocrinological investigation2018

Gemigliptin, a novel dipeptidyl peptidase-IV inhibitor, exerts a synergistic cytotoxicity with the histone deacetylase inhibitor PXD101 in thyroid carcinoma cells.

S H Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.